Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.

Yasuhiro TakedaTakashi AkiyoshiKiyoshi MatsuedaHironori FukuokaAtsushi OguraHisanori MikiYukiharu HiyoshiToshiya NagasakiTsuyoshi KonishiYoshiya FujimotoYosuke FukunagaMasashi Ueno

Published in: PloS one (2018)

Low skeletal muscle mass is an independent negative prognostic factor for relapse-free and overall survival in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.

Keyphrases

rectal cancer
prognostic factors
skeletal muscle
locally advanced
insulin resistance
free survival
squamous cell carcinoma
newly diagnosed
metabolic syndrome
adipose tissue